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Recent studies in the murine system have demonstrated that the activation 
signals  required  to  trigger antibody production by  B  cells  vary considerably 
depending on the nature of the B cell subpopulation under study. For example, 
Asano et al. (1) used major histocompatibility complex (MHC)l-restricted keyhole 
limpet hemocyanin-specific cloned T  helper (Th) cells to study B cell subsets 
distinguished by the presence or absence of the Lyb-5 differentiation antigen. 
They determined that the activation of hapten-specific Lyb-5- B cells requires 
both hapten-carrier linkage and MHC-restricted Th cell-B cell interaction, while 
the  triggering of hapten-specific  Lyb-5 + B  cells  is  unrestricted and does  not 
require carrier-hapten linkage. Other investigators have isolated murine B cell 
subsets  by  virtue  of differences  in  cell  size  or  density,  and  analyzed  their 
interactions with Th cells specific for B cell surface determinants, including male- 
associated (HY) antigen (2-4), allogeneic Ia antigens (5), minor histocompatibility 
determinants (6), or covalently bound hapten (7). These experimental systems, 
in which most if not all B cells bear the target antigen recognized by the Th cell, 
offer the unique advantage of measuring antigen-specific T-B collaboration as a 
polycional  plaque-forming  cell  (PFC)  response.  The  results  of these  studies 
establish that large (partially activated) murine B cells respond readily to nonspe- 
cific, non-MHC-restricted, T  cell-derived helper factor(s).  In contrast, Th cells 
must interact directly with antigen on the surface of small (resting) B cells before 
these B cells become competent to respond to nonspecific helper factor(s). 
Heterogeneity within the human peripheral B cell pool has also been described, 
both with respect to cell surface markers and functional responses to mitogens 
and T  cell-derived helper factors. Thus, the pokeweed mitogen (PWM)-respon- 
sive human B cell is large, of low density, and lacks both surface membrane IgD 
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(8, 9) and receptors for mouse erythrocytes (10). In contrast, small peripheral B 
cells bear receptors for mouse erythrocytes, are surface IgD positive, and respond 
poorly to PWM but relatively well to lipopolysaccharide (LPS) (8, 9). Moreover, 
Muraguchi  et al.  (11)  recently determined  that  while large  human  tonsillar  B 
cells  respond  directly  to  B  cell  growth  factor  (BCGF),  small  B  cells  require 
activation  by anti-#  antibody  before they become competent  to proliferate  in 
response to BCGF. 
Taken  together,  these  observations  serve  to  define  distinct  stages  in  the 
ontogeny of human  B  cells and  suggest strong analogies  to the  murine  B  cell 
differentiative  scheme.  To  date,  however,  the  precise  mechanisms  by  which 
antigen-specific human  Th  cells interact  with these B cell subpopulations have 
not been clearly delineated. To address this important question, we have estab- 
lished  and  functionally  characterized  a  cloned,  trinitrophenyl  (TNP)-specific, 
MHC-restricted human  helper T  cell line (TCL).  Our results demonstrate that 
human B cell subpopulations, isolated by discontinuous density gradient centrif- 
ugation, differ with respect to their requirements for T  cell help. Thus, large B 
cells are highly responsive to nonspecific helper signals generated by the antigen- 
specific,  MHC-restricted  interaction  of Th  cells  and  TNP-modified  antigen- 
presenting  cells (APC).  In contrast,  polyclonal activation of small peripheral  B 
cells requires direct  interaction  of Th  cells with antigen  (TNP) on both the B 
cell and the APC surface. These results are discussed in the context of normal 
human B cell physiology and possible abnormal Th-B cell interactions that may 
lead to autoimmunity. 
Materials and Methods 
Lymphocyte Preparation  and Fractionation.  Fresh  peripheral  blood mononuclear  cells 
were isolated from healthy donors by Ficoll-Hypaque  gradient centrifugation. Adherent 
cells  were  partially  depleted  by incubation  on  plastic  petri  dishes  for  1 h  at  370C. 
Nonadherent cells were fractionated into T  cell-enriched  (E  +) and B cell-enriched  (E-) 
populations by the formation of rosettes with neuraminidase-treated sheep erythrocytes. 
In some studies, the E- population was depleted of any contaminating T cells by comple- 
ment-mediated lysis in the presence of OKT3, a monoclonal  anti-human  T cell antibody 
(12), or subjected to further fractionation on discontinuous Percoll gradients. 
Separation of B Cell Subpopulations  on Density Gradients.  E- cells were fractionated by 
density centrifugation on a discontinuous gradient of Percoll (Pharmacia,  Uppsala,  Swe- 
den) as previously described (9). Briefly, 20-60 x  108 E- cells in 0.5 cc of 30% Percoll in 
phosphate-buffered saline  (PBS) were layered on a discontinuous gradient  of 45-60% 
Percoll in PBS consisting  of 5% increments (2.5 ml vol). Gradients were centrifuged at 
5,000 g for 5 min at 4°C, and layers routinely observed at the 30-45%, 45-50%, and 
50-55% interfaces.  The 45-50% and 50-55% layers were designated large and small B 
cell populations,  respectively  (8, 9). The 30-45% layer was comprised largely of macro- 
phages, and produced very few PFC under the culture conditions  used (data not shown). 
Induction,  Isolation, and Propagation of Cloned TNP Altered Self-reactive TCL.  As previ- 
ously  described  (13),  in  vitro  sensitizations  were  performed  in  sterile  Linbro  MR-2 
microplates  (Linbro Chemical  Co.,  Hamden,  CT).  Each  microwell  contained  2  x  l0 s 
responder T  cells and an equal number of TNP-modified, x-irradiated  E- autologous 
stimulators  in  a  volume  of 0.2  cc  of final  medium,  consisting  of Iscove's modified 
Dulbecco's medium (Gibco Laboratories, Grand Island,  NY) supplemented with 100 mM 
penicillin-streptomycin,  200 mM L-glutamine, and 10% fetal bovine serum (Microbiolog- 
ical Associates, Bethesda,  MD). As in previous studies,  cells were modified with trinitro- 
benzene sulfonic acid (10 mM, pH 7.4, in PBS) for 10 min at 37°C (13). After 10 d of 1446  HUMAN  Th-B CELL  SUBSET  INTERACTIONS 
culture at 37°C in a humid 95% air, 5% CO~ atmosphere, 100 #1 of spent medium was 
aspirated and replaced with an equal volume of fresh final medium containing 2 x  105 
TNP-modified, x-irradiated autologous stimulators. After three additional days of culture, 
responder T  cells were resuspended, washed, and propagated in the presence of interleu- 
kin  2 (IL-2). After 2  wk of growth as a  bulk TCL, the culture was cloned by limiting 
dilution. Briefly, TCL cells were seeded at 1 or 10 cells/well in flat bottomed microtiter 
wells (3596; Costar, Cambridge, MA) in a volume of 0.2 cc of final medium supplemented 
with IL-2 and  1 x  105 x-irradiated, TNP-modified autologous cells.  Microwells were fed 
fresh final medium containing IL-2 every 3-4 d and, after 2-3 wk, growing cultures were 
transferred to macrowells and expanded in the presence of IL-2 and x-irradiated, TNP- 
modified autologous cells.  Of 96 wells seeded at 10 TCL/weI1, 14 cultures were grown, 
whereas only 4 of 96 seeded at  1 TCL/well were successful. These cultures have been 
designated cloned TCL. 
Preparation oflL-2.  As recently reported (14),  the IL-2 used to propagate TCL cells 
was obtained by phytohemagglutinin activation of tumor cells derived from a patient with 
T  cell chronic lymphocytic leukemia. This tumor cell preparation has been termed OT- 
CLL. The active moiety(ies) produced by OT-CLL cells have proven to be both function- 
ally and biochemically similar to conventional human IL-2 but is produced in titers >20- 
fold higher than those obtained from conventional sources. Although each batch of OT- 
CLL-derived IL-2 varied slightly in potency, the crude supernatant was usually added to 
cell cultures at a final concentration of 2.5-5%. 
Phenotypic Analysis  of TCL  Cells.  The  cell  surface  phenotype of the  TCL cells  was 
assessed by indirect immunofluorescence using monoclonal antibodies generously supplied 
by Dr. Gideon Goldstein of Ortho Pharmaceutical Corp., Raritan,  NJ and a fluorescein- 
conjugated  goat  anti-mouse  IgG (Meloy  Laboratories  Inc.,  Springfield,  VA).  Samples 
were assayed using a  model 30-H cytofluorograf (Ortho Instruments, Westwood,  MA). 
The antibodies used in this study included: OKT3 and OKT11, two pan-T cell antibodies 
(12,  15), the latter of which recognizes the E rosette receptor; OKT4, which recognizes 
an  antigen  expressed by the  "helper"  or  "inducer"  T  cell subset  (16);  OKT8,  which 
identifies suppressor/cytotoxic T  cells (17);  OKI1, which binds to the human Ia antigen 
analog (18); and OKM 1, which identifies peripheral blood monocytes (19). 
Proliferative Assay (13).  I ×  104 cloned TCL cells, suspended in 0.1 ml of final medium, 
were co-cultured with an equal volume of final medium alone or final medium containing 
I  x  105 x-irradiated stimulator cells.  Cultures were performed in  Linbro flat-bottomed 
microtiter plates and all experimental ~oints assayed in  triplicate.  After 48  h, cultures 
were pulsed for 16 h  with 0.2 uCi of [ H]thymidine (5 #Ci/mi) (New England Nuclear, 
Boston, MA). Incorporation of radioactivity was measured by liquid scintillation counting 
and data expressed as cpm +  SEM. 
B Cell Helper Assay.  1 ×  105 responder B cells were cultured in flat-bottomed microwells 
in a volume of 0.2 ml of final medium alone or final medium supplemented with varying 
numbers of T  cells,  TCL cells,  x-irradiated APC, or PWM  (10 ~gm/ml), according to 
experimental design. Each culture consisted of three replicate microwells which, after 6 
d  of culture,  were pooled and assayed in triplicate for polyclonal immunoglobulin pro- 
duction  using  the  reverse  hemolytic plaque  assay (13).  Data  is  presented  as  PFC/106 
initially cultured B cells.  SEM was <15%  for all data points. In some studies, total IgM 
and IgG immunoglobulin production were quantitated using class-specific,  enzyme-linked 
immunoabsorbent assays (ELISA) as previously described (20). 
Results 
Establishment of Cloned TNP-specific TCL.  Hapten-specific T  cells were isolated 
by  limiting  dilution  culture  of  an  uncloned  TNP-altered  self-reactive  TCL. 
Briefly, TCL cells were seeded at either  1 or  10 cells/well in microwells contain- 
ing x-irradiated,  TNP-modified autologous stimulators and  IL-2. Growing cul- 
tures were transferred  to macrowells, expanded  by repetitive stimulations with 
IL-2  in  conjunction  with  TNP-modified  feeder  cells,  and  screened  for  TNP- PRINCIPATO,  THOMPSON,  AND  FRIEDMAN  1447 
specific  proliferation.  Because  of excellent  growth  characteristics,  one  clone, 
designated E-11,  was  selected for  more detailed  study. This cloned TCL  has 
been in continuous culture for >1 yr with maintenance of TNP-specific functional 
activity (Table I). E-11 cells have been cryopreserved by standard rate-controlled 
freezing procedures, and thawed with retention of functional, phenotypic, and 
growth characteristics. Currently, >300 x  106 cryopreserved E-11 TCL cells are 
available in our laboratory. 
E-11 Is a TNP-specific MHC-restricted Helper TCL.  Phenotypic characterization 
Experiment 
TABLE  I 
E-I1 Is a TNP-specific  Cloned TCL 
Description of culture 
x-irradiated 
Responder  stimulator 
1  E-11 
[3H]thymidine 
mcorporauon 
cpm + SEM 
--  326 +  17 
A  444 +  82 
AxNp  24,492 _  1,826 
2  E-11  --  339 _+ 86 
A  896 +  144 
AxNp  9960 _  289 
AFtxc  824 :t= 152 
3  E-11  --  166  _  38 
A  140 :t= 47 
AxNp  2,824 +  371 
-- +  IL-2  1,624 +  188 
A +  IL-2  3,155 +  124 
AxNp +  IL-2  8,499 _  522 
1 X  104  E-11  cells were cultured in triplicate with final medium alone 
(--) or  1  x  105  unmodified (A),  TNP-modified (ATNp), or  fluorescein 
isothiocyanate-modified  (ArITC) x-irradiated autologous peripheral blood 
mononuclear cells as stimulators. Some cultures were supplemented with 
IL-2 (Exp. 3). After 48 h of culture, [SH]TdR incorporation was assayed 
as described above. These three experiments represent the proliferative 
response of E-11 after l, 3, and 7 mo of culture, respectively. 
TABLE  II 
Phenotypic Analysis of E-11 
Monoclonal antibody  Percent reactivity by 
immunofluorescence 
Ascites control  4 
T  3  92 
T  llA  93 
T4  95 
T8  6 
I  1  70 
M1  5 
E-11  cells were characterized with  respect to  cell  surface  markers by 
indirect immunofluorescence using the panel of monoclonal antibodies 
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of E-11  with a panel of monoclonal antibodies (Table II) demonstrates that the 
line is homogeneous, comprised of activated  (Ia  +) T  cells belonging exclusively 
to the T3 +, T4 +, T8- subset. We recently reported that cloned HLA-DR-specific 
human TCL, which express this phenotypic profile, can induce a polyclonal PFC 
response by B cells that bear the relevant  DR antigen  (21).  We were therefore 
interested  to determine if the E-11  TCL also mediates antigen-specific  help for 
B cells. To this end, E-11 cells were co-cultured with unmodified, TNP-modified, 
or,  in  some  studies,  fluorescein  isothiocyanate  (FITC)-modified  autologous  B 
cells.  After  6  d,  polyclonal  B  cell  activation  was  determined  in  the  reverse 
hemolytic PFC assay. The results of two representative experiments, depicted in 
Fig.  1,  demonstrate clearly  that  E-11  provides potent antigen-specific  help for 
TNP-modified autoiogous B cells.  To rule out the possibility that this apparent 
antigen-specific  B cell activation merely reflects differences  in the kinetics of E- 
l 1-induced  PFC responses,  day  10 culture  supernatants were assayed  for total 
IgM and IgG production using class-specific  ELISA systems. As shown in Table 
III,  these  studies  serve  to  confirm  that  E-11  is  a  TNP-specific  helper  TCL. 
Finally, E-11  helper activity is radioresistant and independent of contaminating 
T  cells (data not shown). 
To evaluate whether E-11  help is MHC restricted,  as well as antigen specific, 
E-11 cells were co-cultured with unmodified or TNP-modified E- cells obtained 
from a  panel  of allogeneic  donors of known  HLA-DR  haplotype.  The  results 
(Table IV) demonstrate that help is observed only when E-11  is co-cultured with 
Exp. I 
DESCRIPTION  PFC /  IO s  CELLS 
OF  CULTURE  250  500  750  IOOO  1250  1500 
l  l  i  I  I  f 
8cells  Tcei[$  PWM 
m, 
r 
B 
B  T  - 
B  T  + 
B  E-II  - 
8TN P 
8TN  P  T  - 
BTNP  T  + 
BTNp  E-i I  - 
BFLTC 
8FITC  T  - 
8FITC  T  4" 
BFITC  E-II  -- 
Exp. 2  B  T  - 
B  T  + 
8  E-II  - 
BTN  e  T  -- 
BTN  P  T  + 
BTNP  E-II  - 
FIGURE 1.  E-1 1 is a TNP-specific helper TeL. Unmodified (B), TNP modified (BTNP), or 
FITC modified (Bv,TC) E- cells were cultured alone, with 90% autologous T  cells, or an equal 
number of E-11 TCL cells. As a positive control, some cultures were supplemented with PWM. 
After 6 d, aliquots of each culture were assayed in triplicate for PFC activity. Data is expressed 
as  PFC/106  initially  cultured  E-  cells.  In  both  experiments,  the  E-  responder  cells  are 
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TABLE III 
E-11 Is a TNP-specific  Helper TCL 
Description of culture  IgM  IgG 
ngm/ml 
B +  T  +  media  <125  <10 
B +  T  +  PWM  65,000  290 
B +  E-I 1  <125  <10 
BTNp +  T  +  media  <125  <10 
BTNp at" T  +  PWM  131,660  375 
BvNe +  E-I 1  94,830  615 
Unmodified (B) or TNP-modified (Brrw) E- cells, obtained from a DR 5  + 
donor, were cultured with final medium alone, 20% autologous T  cells, 
or an equal  number of E-I 1 cells.  As a  positive control, some cultures 
were supplemented with PWM. After 10 d of culture, supernatants were 
harvested and assayed for total IgM and IgG using class-specific ELISA 
systems. 
TNP-modified ailogeneic  cells  that  express  the  DR5  allele.  This  pattern  of 
restriction was not anticipated, since the donor of E-11 types is DR 2,8. Although 
the explanation for this apparently anomalous result remains to be found, two 
points should be emphasized. First, E-11 does not provide help for TNP-modified 
DR 2-positive B cells (Table III, donor G).  Second, the DR 8 antigen remains 
poorly characterized and is known to cross-react with some DR 5-specific allo- 
antisera. Therefore it is reasonable to suggest that E-11  is restricted by a "self" 
determinant, present perhaps on the DR 8 antigen, which is either coexpressed 
on the DR 5 allele, or expressed on a  polymorphic structure distinct from but 
closely linked to the DR 5 allele. Although more detailed immunogenetic studies 
are required to clarify this point, our results strongly suggest that E-11 recognizes 
the nominal antigen, TNP, in the context of a class II MHC determinant. 
E-11  Help  Is  Restricted  at  the  Inductive  Level.  Antigen specificity and  MHC 
restriction of E-11  helper activity may operate at the inductive level (Th-APC 
interaction), the effector level (Th-B cell interaction), or both.  To distinguish 
among these possibilities, we first asked if E-11 could provide help for irrelevant 
(bystander) B cells and, if so,  under what conditions. To this end, E-11  was co- 
cultured with unmodified allogeneic responder B cells, either DR5 + or DR5-, 
and the cultures further supplemented with  unmodified or  TNP-modified x- 
irradiated  stimulator  cells.  The  results  of two  representative studies  (Fig.  2) 
demonstrate that  E-11  can  trigger a  polyclonal PFC  response by  unmodified 
responder B cells, regardless of their MHC haplotype. It should be emphasized, 
however, that  this result requires the presence of x-irradiated stimulator cells 
that bear both TNP and the appropriate MHC-restriction antigen (DR5). These 
results demonstrate that  E-11  helper activity is antigen specific and MHC  re- 
stricted at  the  inductive  (Th-APC)  level,  but  appears  to  be  at  least  partially 
unrestricted and nonspecific at the effector level. 
E-11 Help Is Partially Restricted at the Effector Level.  Inductive level restriction 
of E-11 helper activity is consistent with our data concerning allospecific helper 
TCL (21).  In those studies, we noted that the level of help that aliospecific Th 
cells can provide for appropriate allogeneic B cells is often significantly greater 1450  HUMAN  Th-B  CELL  SUBSET  INTERACTIONS 
TABLE  IV 
E-11 Is an Antigen-spec~c MHC-restricted  Helper TCL 
PFC/106  PFC/106 
Description of culture  cells  Description of culture  cells 
Donor A (DR 5,7)  Donor C (DR 1,3) 
B+T  135  B+T  75 
B + T  +  PWM  4,585  B + T  +  PWM  1,725 
B +  E-11  150  B +  E-11  150 
BTNP q" T  192  BTNP + T  45 
BTNP +  T  +  PWM  3,010  BTNP +  T  +  PWM  425 
BTNP +  E-11  2,270  BTNP +  E-11  75 
Donor B (DR  1,7)  Donor D (DR 1,3) 
B+T  15  B+T  70 
B +  T  +  PWM  970  B + T  +  PWM  1,135 
B+E-II  84  B+E-11  170 
BqrNe +  T  25  BTNP + T  220 
B-rNP +  T  +  PWM  570  BTNP +  T  +  PWM  2,260 
BTNe +  E-11  68  BTNp +  E-11  165 
Donor E (DR -,5)  Donor G (DR 2,3) 
B+T  165  B+T  52 
B +  T  +  PWM  1,420  B + T  +  PWM  1,028 
B +  E-11  140  B +  E-11  68 
BTNP +  T  250  BTNP + T  24 
B-vNp + T  +  PWM  7,840  BTNP +  T  +  PWM  780 
BTNe +  E-11  6,620  BTNP +  E-11  59 
Donor F (DR 3,5)  Donor H (DR 1,4) 
B  +  T  180  B  +  T  140 
B +  T  +  PWM  1,240  B + T  +  PWM  980 
B+E-11  170  B+E-I1  120 
BTNp -t- T  24  BTNP +  T  110 
B-rNp +  T  +  PWM  NT  BTNP +  T  +  PWM  720 
BTNP +  E-I 1  940  BTNP +  E-11  120 
Unmodified (B)  or  TNP-modified (BTNP) E-  cells, obtained from a  panel  of 
allogeneic donors of known  HI.A-DR haplotype, were co-cultured with  20% 
autologous T  cells or an equal number of E-11 cells. As a positive control, some 
cultures were supplemented with PWM. After 6 d, PFC activity was assayed as 
described for Fig. 1. NT, not tested. 
than that obtained with PWM. This observation suggested that B cells which did 
not respond to PWM-induced T  cell help may be activated by direct interaction 
with the allospecific Th cell. In this regard, E-11 may also trigger PFC responses 
by TNP-modified autologous or DR 5 + allogeneic B cells that are greater than 
those induced by PWM (Fig.  1). To determine if this result reflects preferential 
interaction  of  E-11  with  TNP-modified  B  cells,  the  following  studies  were 
performed. Varying numbers of E-11  cells were cultured with DR 5 + aliogeneic 
E-  populations  comprised  of equal  numbers  of either  unmodified  responders 
and  TNP-modified  x-irradiated  stimulators,  or TNP-modified responders  and 
unmodified x-irradiated  stimulators.  After 6 d, polyclonal PFC respop~es were 
assessed. We observed (Fig. 3) that although E-11 can recruit a PFC response by 
unmodified bystander cells, TNP-modified  B cells are preferentially activated. 
Similar evidence for preferential  interaction of E-11  with TNP-modified B cells 
is demonstrated in the experiment presented in Table V. Taken together, these Exp. I 
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FIGURE 2.  E-11  is TNP specific and MHC restricted at the inductive level. Unmodified E- 
responder cells, obtained from a  DR  5 + (experiment  1) or a  DR  5- (experiment  2) donor, 
were cultured alone or with 20% E-] 1 TCL cells. Some cultures were supplemented with 20% 
x-irradiated E- cells as APC. The APC were DR 5- (A) or DR 5 ÷ (B) and either unmodified 
or TNP modified, as indicated. After 6 d, PFC activity was assayed as described for Fig. 1. 
1500" 
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FmUR~  3.  E-11  preferentially activates TNP-modified  B  cells.  Varying numbers of E-I 1 
TCL cells were cultured with DR 5 ÷, E- allogeneic responder cells. The responder populations 
consisted of equal numbers of TNP-modified cells and unmodified x-irradiated E- cells (BTNe 
+  B~,), or TNP-modified x-irradiated cells and unmodified E- cells (BTNPx, +  B).  After 6  d, 
PFC activity was assayed as described for Fig.  1. To determine maximal PFC activity, both E- 
responder populations were  cultured with 20% autologous T  cells and  PWM.  These  PFC 
responses were  1,260 (BTNp +  Bxr) and 1,057 (B'rNPxr +  B). 
results  strongly  suggest  antigen-specific  interaction  at  the  Th-B  cell  level,  and 
served as the impetus  for the studies which  follow. 
E-11 Helps B Cell Subsets through Distinct Pathways.  As described  above,  studies 
in the murine  system  have  shown  that partially activated  (large)  B  cells respond 1452  HUMAN  Th-B  CELL SUBSET INTERACTIONS 
TABLE  V 
E-11 Preferentially Activates TNP-modified B Cells 
Description of culture 
x-irradiated  Responder B cells  APC  Helper TCL 
PFC/IO  6 
--  --  190 
B  --  270 
BTNP  --  170 
B  E-I1  160 
BTNP  E-11  515 
cells 
BTNP  --  --  215 
B  --  295 
BTNp  --  200 
B  E-11  1,900 
B'rNp  E-11  3,520 
Unmodified (B) or TNP-modified (BTNP) E- cells, obtained from a DR 5  ÷ 
donor, were cultured  alone or in the presence of 20%  unmodified or 
TNP-modified x-irradiated autologous E- cells as APC. Some cultures 
were further supplemented with 20% E-11 TCL cells. After 6 d, PFC 
activity was assayed as described for Fig. 1. 
directly to nonspecific helper signals  (factors) released by antigen-activated Th 
cells, while resting (small) B cells require direct interaction with Th cells before 
they  can  be  triggered  to  produce  antibody.  We  were  therefore  interested  to 
determine if the differences that we observe between "recruited" and "direct" 
help by E-1 1 reflect distinct pathways of activation by which the Th cell interacts 
with different human B cell subpopulations.  To this end, B cell-enriched popu- 
lations were fractionated by discontinuous density gradient  centrifugation and 
the  subsets  obtained  assayed  for  their  response  to  E-1 1  helper  activity.  The 
results  of two  separate  experiments  are  presented  in  Table  VI.  As  shown  in 
experiment  1,  antigen-activated  E-1 1  cells  readily  trigger  a  PFC  response  by 
both  unmodified  and  TNP-modified  large  B  cells.  In  marked  contrast,  TNP- 
modified, but not  unmodified,  small  B  cells are  selectively driven  to antibody 
production by E-1 1. In experiment 2, E-1 1 TCL cells were "preactivated" at the 
time of assay, presumably by interaction with TNP-modified APC during IL-2- 
dependent expansion. Interestingly, although both unmodified and TNP-modi- 
fled large B cells are polyclonally triggered by co-culture with these activated Th 
cells,  only TNP-modified small  B  cells are responsive.  It should be noted that 
the  interaction  of E-1 1  with  TNP-modified small  B  cells  is  required,  but  not 
sufficient,  to  trigger  a  PFC  response;  TNP-modified APC  are  also  necessary. 
Moreover,  the  requirement  for  TNP-modified  APC  is  also  observed  in  the 
activation of large B cells (Table VI, experiment 1) and cannot be overcome by 
merely increasing the percentage of E-1 1 cells in culture (Fig. 4). Taken together, 
these results demonstrate that large human peripheral blood B cells are readily 
induced to antibody secretion by E-1 1 in an unrestricted and nonspecific manner, 
provided  that  E-1 1  has  been  activated  by  TNP  on  the  appropriate  APC.  In 
contrast, small B cells require an additional signal, which appears to be delivered 
by direct antigen-specific interaction of E-1 1 and TNP-modified B cells. PRINC1PATO,  THOMPSON,  AND  FRIEDMAN  1453 
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TABLE  VI 
Antigen-specific  Th-Small B Cell Interaction 
Description  of culture 
Responder  B  x-irradiated  Helper TCL 
cells  APC 
PFC/106 cells 
lg B  E-  --  330 
E-TNP  --  315 
E-  E-11  320 
E--TNP  E-11  1,837 
lg BTNp  E-  --  40 
E--TNP  --  50 
E-  E-11  50 
E-TNP  E-11  1,075 
sm B  E-  E-11  155 
E-TNP  E-I 1  330 
sm  BTNP  E-TNP  --  100 
E-  E-11  260 
E-TNP  E-11  1,425 
2  lg B  E-  --  660 
E--TNe  --  475 
--  E-11  4,415 
Ig BTNP  E-  --  450 
E-TNp  --  305 
--  E-11  4,550 
sm B  E-  --  55 
E-TNP  --  120 
--  E-11  65 
sm  BTNP  E-  --  50 
E-TNP  --  65 
--  E-11  750 
Responder populations,  in both experiments,  consisted  of unmodified or 
TNP-modified large (lg  B) and small (sm B)  DR  5 ÷  B  cells, isolated  by 
discontinuous density gradient centrifugation.  As indicated, some cultures 
were supplemented  with 30%  unmodified (E-) or TNP-modified (E-TNP) 
x-irradiated  autologous  E-  APC,  30%  E-I 1  TCL  cells  were  added  as 
indicated. After 6  d, PFC activity was assayed as described for Fig.  1. 
Discussion 
In this report we have investigated human Th-B cell interactions through the 
isolation and functional characterization  of a cloned TNP-altered,  self-reactive 
helper TCL,  termed  E-11.  Our results show that co-culture of E-11  cells with 
TNP-modified, but not unmodified or FITC-modified, autologous B cells results 
in  a  vigorous  polyclonal  PFC  response.  Moreover,  in  panel  studies  involving 
allogeneic responder B cells,  E-11  selectively triggers a PFC response by TNP- 
modified allogeneic  B  cells  that express  the  DR  5  allele,  suggesting  that  E-11 
recognizes the nominal antigen TNP in the context of a class  II MHC determi- 1454  HUMAN  Th-B  CELL  SUBSET  INTERACTIONS 
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FIGURE 4.  E-11  help  requires  TNP-modified  APC.  Large  TNP-modified  DR  5 +  B  cells 
isolated by discontinuous density gradient centrifugation were cultured with 20% unmodified 
(O) or TNP modified (0) autologous x-irradiated E- cells. Cultures were supplemented with 
varying percentages of E-11  TCL cells. After 6 d,  PFC activity was assayed as described for 
Fig.  1. In the absence of E-11 cells, both populations gave essentially identical PFC responses 
(D). 
nant. Analysis of the mechanisms by which E-11 mediates antigen-specific, MHC- 
restricted  help demonstrated that the interaction of E-11  with TNP-modified 
DR 5 + APC is a necessary and sufficient trigger for the induction of a polyclonal 
PFC response by bystander B cells (e.g.,  unmodified and DR  5- B cells). This 
observation  suggests  that  E-11  is  not  a  constitutive  helper  cell,  but  requires 
antigen-specific, MHC-restricted activation. Further, it shows that E-11 help for 
B cells is at least partially nonspecific and unrestricted at the effector (Th-B cell) 
level. 
Although the precise nature of the APC that activates E-11  help remains to 
be defined, it appears that the relevant cell is a macrophage. This conclusion is 
suggested by the observation that although E rosette-negative cells can function 
as  APC,  removal  of macrophages  by  plastic  adherence  and  density  gradient 
centrifugation yields a highly purified B cell population that can respond to but 
not induce E-11  help. It should be emphasized that in this experimental system, 
hapten is covalently coupled to the cell surface; therefore, both TNP-modified 
macrophage and B cell populations express the target antigen recognized by E- 
l 1. The most likely explanation for the crucial role of macrophages in activating 
E-11 is that interaction of E-11 with hapten (TNP)- and MHC-restricting elements 
on the macrophage surface triggers the macrophage to release IL-1, which, in 
turn, signals antigen-activated E-11  cells to secrete nonspecific helper factor(s) 
capable  of  recruiting  bystander  B  cells.  In  this  regard,  we  have  previously 
reported that after antigen-specific activation, TNP-ahered, self-reactive human 
helper TCL cells elaborate nonspecific helper factor(s) that induce a  polyclonal 
PFC response (13). 
Perhaps the most interesting point to emerge from these studies is the dem- 
onstration that a cloned, antigen-specific Th cell activates human B cell subpop- 
ulations  via  two distinct  mechanisms. Thus,  large  B  cells,  isolated by  Percoll PRINCIPATO,  THOMPSON,  AND  FRIEDMAN  1455 
density centrifugation,  respond directly to the helper signals provided by the 
interaction of E-11 with TNP-modified DR 5 + APC. This response is nonspecific, 
nonrestricted, and does not involve direct Th-B cell contact.  In contrast, poly- 
clonal activation of small B cells by E-11  requires that the B cells bear TNP on 
their surface and that TNP-modified APC be also present. These data suggest 
that direct interaction between Th cells and antigen on the B cell surface provides 
an important activation signal for the small B cell which allows responsiveness to 
helper  signals  generated  by  Th-APC  interaction.  This  scheme  of Th-B  cell 
collaboration is depicted in Fig. 5. We would emphasize that these findings are 
consistent with published data concerning human B cell subset activation.  For 
example, polyclonal activation of large B cells by helper signals (factors) generated 
during the Th-APC interaction is in accord with the observations that large B 
cells are responsive to T  cell-derived factor(s) (e.g., BCGF) (11), and the T  cell- 
dependent lectin PWM (8, 9), which is known to trigger helper factor production 
by T  cells (22).  In contrast, small resting B cells are refractory to T  cell helper 
factor(s) unless they receive an additional activation signal. This signal may be 
provided by: (a) cross-linking of the B cell receptors for antigen by anti-IgM (11); 
(b) LPS (9), a T-independent lectin that is known to substitute for the Th-B cell 
interaction signal in the activation of murine B cells (2); and (c) as shown in this 
report, direct Th cell interaction with antigen on the B cell surface. It has been 
suggested that,  together,  Th-APC and Th-B cell interactions are  sufficient to 
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FIGURE 5.  Pathways of Th-B cell subset  interaction.  Large human  peripheral  B  cells are 
driven to Ig secretion by the helper signals (factors) produced during the interaction of Th 
cells with antigen- and MHC-restricting elements on the surface of antigen presenting mac- 
rophages (4)). Small B cells are resistant to these helper signals unless an additional trigger is 
provided: the direct ceil-cell interaction of Th cells with antigen on the B cell surface. Although 
Th-small B cell interaction alone is not sufficient to trigger Ig production, it is not known if 
this signa  ! can drive the small B cell to a more activated stage of differentiation (e.g., a large 
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trigger the maturation  of resting murine B  cells to immunoglobulin-secreting 
cells, while antigen functions to selectively expand antigen-specific B cell clones 
(2).  By extension,  one  might predict that  the  combined stimulus of anti-IgM 
antibody and  antigen-specific Th  cells would synergize  in  the  induction  of a 
polyclonal immunogiobulin response by antigen-bearing resting human B cells. 
Moreover, it is possible that the addition of a particular antigen to the Th-B cell 
system we have described may induce a  specific antibody response against any 
antigen for which specific B cells are present. 
The biologic significance of human Th cells that recognize, interact with, and 
polycionally activate modified autologous B cells remains to be elucidated. It is 
intriguing, however, that similar interactions, by adoptively transferred allospe- 
cific murine Th cells, are postulated to be responsible for the polyclonal immu- 
noglobulin  response  that  characterizes  chronic  graft-vs.-host  disease  (GVHD) 
(23). Of particular interest is the observation that in certain strain combinations 
the abnormal  T-B  collaboration  induced during chronic GVHD  leads  to  the 
appearance  of autoantibodies  and  immune  complex  disease  characteristic  of 
systemic lupus erythematosus (SLE) (24, 25). Moreover, autoimmune phenome- 
non  characteristic  of the  "collagen  vascular"  diseases  are  known sequelae  of 
chronic  GVHD  in  man  (26).  Our  results  provide  an  experimental  basis  for 
explaining how abnormal T-B cell collaboration could operate in the pathogen- 
esis of "spontaneously arising" human SLE. For example, one may envision that 
in some individuals the presence of exogenous antigen (e.g., viral determinants) 
on cell surfaces may result in a predominantly helper, rather than cytotoxic, T 
cell response. Collaborative interaction between these Th cells and virally mod- 
ified small B cells would lead to polyclonal activation. Moreover, the continuous 
presence of self-antigens  may  serve  to  specifically expand autoreactive  B  cell 
clones, yielding a preponderance of autoantibody in the polyclonal response. To 
evaluate this hypothesis, we are currently investigating the capacity of E-11  to 
induce, in vitro, anti-double-stranded DNA antibody production by normal and 
SLE patients' B cells. 
Summary 
A  cloned, trinitrophenyl (TNP)-specific helper T  cell line (TCL), termed E- 
l 1, has been established in long-term, interleukin 2-dependent culture and used 
to  study  human  T  helper  (Th)-B  cell  collaboration.  Co-culture  of E-11  with 
TNP-modified, but not unmodified or FITC-modified, autoiogous B cells results 
in  a  vigorous,  polyclonally  plaque-forming  cell  (PFC)  response.  E-11  helper 
activity is not constitutive, but requires antigen-specific, major histocompatibility 
complex-restricted activation of the TCL cells by interaction with TNP-modified 
autologous or DR 5 ÷ aliogeneic macrophages. Using B cell subsets isolated by 
discontinuous  density  gradient  cengrifugation  as  responder  populations,  we 
determined that E-I 1 activates B cell subsets via two distinct mechanisms: (a) E- 
l 1 polyclonal[y activates large B cells in an unrestricted and nonspecific manner; 
and (b)  E-11  preferentially  induces a  PFC  response by TNP-modified small B 
cells.  These  results  suggest that  the large  B  cell  subset  is activated  by  helper 
signals generated during the Th-antigen-presenting cell interaction, while small 
B cells require an additional stimulus that is provided by antigen-specific Th-B PRINCIPATO,  THOMPSON,  AND  FRIEDMAN  1457 
cell contact. 
We wish to thank Dr. Nicole Sucia-Foca for performing the HLA typing of the donors 
used in this study and Dr. Leonard Chess for his encouragement and help throughout all 
phases of this work. 
Received  for publication 31 May 1983 and in revised  form 26July 1983. 
References 
1.  Asano, Y., M. Shigeta, C. G. Fathman, A. Singer, and R.J. Hodes. 1982. Role of the 
major histocompatibility complex in  T  cell activation of B cell subpopulations.  A 
single monoclonal T  helper cell population activates different B cell subpopulations 
by distinct pathways.J. Exp. Med. 156:350. 
2.  Zubler,  R.  H.,  and  O.  Kanagawa.  1982.  Requirement for three signals  in  B  cell 
responses. II. Analysis of antigen and Ia-restricted T  helper cell-B cell interaction. J. 
Exp. Med. 156:415. 
3.  Julius, M. H., H. von Boehmer, and C. L. Sidman.  1982. Dissociation of two signals 
required for activation of resting B cells. Proc. Natl. Acad. Sci. USA 79:1989. 
4.  Pettersson, S., G. Pobor, and A. Continho.  1982. MHC restriction of male-antigen- 
specific T  helper cells collaborating in antibody responses. Immunogenetics. 15:129. 
5.  Andersson, J.,  M.  H.  Schreier, and  F.  Meichers.  1980.  T  cell-dependent  B  cell 
stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. 
Proc. Natl. Acad. Sci. USA. 77:1612. 
6.  Coutinho, A., and A. A. Augustin. 1980. Major histocompatibility complex-restricted 
and unrestricted T  helper cells recognizing minor histocompatibility antigens on B 
cell surfaces. Eur. J. Immunol.  19:525. 
7.  Martinez-Alonso, C., and A. Coutinho. 1981. B-cell activation by helper cells is a two- 
step process. Nature (Lond.). 290:60. 
8.  Kuritani, T., and M. D. Cooper.  1982. Human B cell differentiation. II. Pokeweed 
rnitogen-responsive  B  cells  belong  to  a  surface-immunoglobulin  D-negative  sub- 
population.J. Exp. Med. 155:1561. 
9.  Dagg,  M. K., and D.  Levitt.  1981. Human B lymphocyte subpopulations. I. Differ- 
entiation of density-separated B lymphocytes. Clin. Immunol. hnmunopathol. 21:39. 
!0.  Lucivero, G., A. R. Lawton, and M. D. Cooper. 1981. Rosette formation with mouse 
erythrocytes  defines a population of human B lymphocytes unresponsive to pokeweed 
mitogen. Clin. Exp. Immunol. 45:185. 
11.  Muraguchi, A.,J. L. Butler,J. H. Kehrl, and A. S. Fauci. 1983. Differential sensitivity 
of human  B  cell  subsets  to  activation  signals  delivered  by  anti-u  antibody  and 
proliferative signals  delivered by a  monoclonal B cell growth factor. J.  Exp. Med. 
157:530. 
12.  Kung, P. C., G. Goldstein, E. L. Reinherz, and S. F.Schlossman.  1979. Monoclonal 
antibodies defining distinctive human  T  cell surface antigens.  Science (Wash. DC). 
206:347. 
13.  Friedman,  S.  M.,  S.  B.  Hunter,  Y.  Thomas, and  L.  Chess.  1980.  Hapten-specific 
human T cell lines. I. Functional analysis with respect to cytotoxic and helper activity. 
J. Immunol.  125:2202. 
14.  Friedman, S.  M.,  G. Thompson, J.  P.  Halper, and D.  Knowles.  1982. OT-CLL: a 
human T  cell chronic lymphocytic leukemia which produces IL-2 in high titer. J. 
hnmunol.  128:935. 
15.  Verbi, W., M. F. Greaves, C. Schneider, K. Koubek, G. Janossay, H. Stein, P. Kung, 
and G. Goldstein.  1982. Monoclonal antibodies OKT11 and OKT11A have pan-T 1458  HUMAN  Th-B  CELL  SUBSET  INTERACTIONS 
reactivity and block sheep erythrocyte "receptors." Eur. J. Immunol.  12:81. 
16.  Reinherz,  E.  L.,  P.  C.  Kung,  G.  Goldstein,  and  S.  F.  Schlossman.  1979.  Further 
characterization of the human inducer T  cell subset defined by monoclonal antibody. 
J. bnmunol.  123:2894. 
17.  Reinherz, E. L., P. C. Kung, G. Goldstein, and S. F. Schlossman. 1980. A monoclonal 
antibody  reactive  with  the  human  cytotoxic/suppressor  T  cell  subset  previously 
defined by a heteroantiserum termed TH2. J. lmmunol.  124:1301. 
18.  Reinherz, E. L., P. C. Kung,J. M. Pesando,J. Ritz, G. Goldstein, and S. F. Schlossman. 
1979.  Ia determinants  on  human  T  cell subsets defined by monocional antibody. 
Activation stimuli required for expression. J. Exp. Med.  150:1472. 
19.  Breard, J., E. L. Reinherz, P. C. Kung, G. Goldstein, and S. F. Schlossman.  1980. A 
monoclonal antibody reactive with human peripheral blood monocytes. J. Immunol. 
124:1943. 
20.  Friedman,  S.  M.,  M.  A.  Principato,  G.  S.  Thompson,  and  F.  Teichman.  1983. 
Antigen-specific and  polyclonal  immunoglobulin  production  induced  by a  cloned 
tetanus toxoid-specific T  cell line.J. Immunol.  130:1164. 
21.  Friedman, S. M., G. S. Thompson, and M. A. Principato.  1982. Allospecific human 
T  cell lines and clones which mediate HLA-DR restricted helper activity. J. Immunol. 
129:2451. 
22.  Keightley, R. G., M. D. Cooper, and A. R. Lawton. 1976. The T  cell dependence of 
B cell differentiation induced by pokeweed mitogen. J. Immunol.  117:1538. 
23.  Rolink,  A.  D.,  T.  Radaszkiewicz,  S.  T.  Pals,  W.  G. J.  Van  der  Meer,  and  E. 
Gleichmann.  1982. Allosuppressor and allohelper T  cells in acute and chronic graft- 
versus-host disease. I. Alloreactive suppressor cells rather than killer T  cells appear 
to  be  the  decisive  effector  cells  in  lethal  graft-versus-host disease. J.  Exp.  Med. 
155:1501. 
24.  Gleichmann, E.,  P.  Isaa, E.  H. Van  Elven, and M.  C.  Lamero.  1978.  The chronic 
graft versus host reaction: a lupus erythematosus syndrome caused by abnormal T-B 
cell interactions. Clin. Rheum. Dis. 4:586. 
25.  Gleichmann,  E.,  E.  H. Van  Elven, and J.  P.  w.  Van  der  Venn.  1982.  A  systemic 
lupus erythematosus-like disease in mice induced by abnormal T-B cell cooperation. 
Preferential  formation  of auto-antibodies  characteristic  of SLE.  Eur.  J.  Immunol. 
12:152. 
26.  Shulman, H. M., K. M. Sullivan, P. L. Weider, G. B. McDonald, G. E. Striker, G. E. 
Sale,  R.  Hackman, M.  S.  Tsoi, R. Storb, and E.  D. Thomas.  1980.  Chronic graft- 
versus-host  syndrome in  man.  A  long-term clinicopathologic  study  of 20  Seattle 
patients. Am. J. Med.  69:204. 